People can lower their risks of getting many common kinds of cancer by making healthy choices. Screening tests can find some cancers early when treatment works best. Vaccines (shots) can help prevent several kinds of cancer. Learn more about how to lower your risk of getting cancer.
Dr. Loren Mosher, in an interview for “Changing Our Minds” (http://www.changingourmindsmovie.com for complete DVD), a documentary on mental health, talks about the Soteria project, a long term study on alternative, non-neuroleptic drug treatments for schizophrenia. Purchase the complete DVD at http://www.changingourmindsmovie.com
Targeting calcium signaling in neurons represents a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study published in Biological Psychiatry.
“This is the first time that human neurons are made and characterized from schizophrenia patients with the 16p11.2 duplication, one of the most prominent genetic risk factors in schizophrenia, and the first time that calcium signaling is found as a central abnormality in schizophrenia neurons,” said Peter Penzes, Ph.D., the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences and senior author of the study.
Schizophrenia is characterized by auditory and visual hallucinations, delusions, and trouble with forming and sorting thoughts, which severely impacts productivity and overall quality of life. The disease, which affects roughly one percent of the general population, has strong genetic associations, however the exact genes involved are unknown.
This is a talk given to the Department of Biotechnology at Indian Institute of Technology Madras in January 2023.
A 3D mesh is a three-dimensional object representation made of different vertices and polygons. These representations can be very useful for numerous technological applications, including computer vision, virtual reality (VR) and augmented reality (AR) systems.
Researchers at Florida State University and Rutgers University have recently developed Wi-Mesh, a system that can create reliable 3D human meshes, representations of humans that can then be used by different computational models and applications. Their system was presented at the Twentieth ACM Conference on Embedded Networked Sensor Systems (ACM SenSys ‘22), a conference focusing on computer science research.
“Our research group specializes in cutting-edge wi-fi sensing research,” Professor Jie Yang at Florida State University, one of the researchers who carried out the study, told Tech Xplore. “In previous work, we have developed systems that use wi-fi devices to sense a range of human activities and objects, including large-scale human body movements, small-scale finger movements, sleep monitoring, and daily objects. Our E-eyes and WiFinger systems were among the first to use wi-fi sensing to classify various types of daily activities and finger gestures, with a focus on predefined activities using a trained model.”
A Quebec hospital adopts a novel use of VR to help patients with anxiety, phobias and pain.
In a newswire release today, the Fondation de l’Hôtel-Dieu d’Alma (the Alma Hospital Foundation) announced the launch of a virtual reality (VR) project aimed at improving the mental health of those experiencing increasing anxiety. The Alma Hospital is a regional health centre for the area of Lac St. Jean and the Saguenay River valley to the north of Quebec City.
Jean Lamoureux, the hospital’s Executive Director states, “The number of requests for mental-health consultations is estimated to have increased by 30 to 40 percent during the pandemic. These needs are urgent…and, thanks to the innovation of Paperplane Therapeutics and TELUS, we will transform the way health services are delivered, while having a significant positive impact on patient well-being through technology.”
Human civilization has achieved some incredible things during its short reign on this planet. Technological development over the past 5,000 years of human civilization has led our species to dominance of life on Earth and placed us on a pathway to achieving a Type I civilization.
To reach even the basic level of a “Kardashev Type 1 civilization” we must do two things:
Develop more advanced technology and share it with all responsible nations.
Make renewable energy accessible to all parts of the world.
Five hundred years ago, the Aztec civilization believed that the sun and all its power was sustained by blood from human sacrifice.
Today, we know that the sun, along with all other stars, is powered by a reaction called nuclear fusion.
Scientists and engineers have studied the Sun’s fusion process in hopes of developing a way to harness energy from fusion in machines on Earth.
What exactly is nuclear fusion, and how does it work in terms of producing electricity?
Very old brain, some ancient philosophy maybe…
A fossilised fish originally dug up more than a century ago in an English coal mine has been shown to hold the world’s oldest brain in a vertebrate animal.
CT scans revealed the new internal features including a brain and cranial nerves about 2 centimetres long.
Soft tissue such as internal organs decay very quickly and very rarely fossilise.
Engineers at the University of Waterloo have developed artificial intelligence (AI) technology to predict if women with breast cancer would benefit from chemotherapy prior to surgery.
The new AI algorithm, part of the open-source Cancer-Net initiative led by Dr. Alexander Wong, could help unsuitable candidates avoid the serious side effects of chemotherapy and pave the way for better surgical outcomes for those who are suitable.
“Determining the right treatment for a given breast cancer patient is very difficult right now, and it is crucial to avoid unnecessary side effects from using treatments that are unlikely to have real benefit for that patient,” said Wong, a professor of systems design engineering.
Advancing Geroscience & Gerotherapeutics — Dr. Nir Barzilai, MD, Albert Einstein College of Medicine.
Dr. Nir Barzilai, MD (https://www.einsteinmed.edu/faculty/484/nir-barzilai/) is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.
Dr. Barzilai’s research interests are in the biology and genetics of aging, with one focus of his team on the genetics of exceptional longevity, where they hypothesize and demonstrate that centenarians (those aged 100 and above) may have novel protective genes, which allow the delay of aging or for the protection against age-related diseases. The second focus of his work, for which Dr. Barzilai holds an NIH Merit award, is on the metabolic decline that occurs during aging, and his team hypothesizes that the brain leads this decline with some very interesting neuro-endocrine connections.
